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Abstract Transfer of MPEG19oo-DSPE from micellar phase to 
pre-formed liposomes imparts long in vivo circulation half-life to 
an otherwise rapidly cleared lipid composition. MPEG19oo- 
DSPE transfers efficiently and quickly in a time and temperature 
dependent manner. There is negligible content leakage and a 
strong correlation between assayed mol% MPEG19oo-DSPE, 
liposome diameter increase, and pharmacokinetic parameters 
such as distribution phase half-life. Since a biological attribute 
(liposome clearance rate) can be modified by the insertion 
process, it suggests a simple and economical way to impart site- 
specific targeting to a variety of liposome delivery systems. This 
method is also a convenient way to measure the 'brush' thickness 
of such conjugates directly. 
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1. Introduction 
stability in solvent, or be incompatible with various stages of 
manufacture. In addition, it would be advantageous if a single 
preparation of liposome-encapsulated drug could be divided 
and customized with a variety of inserted targeting candidates. 
Lipid monomers are known to transfer from one lipid phase 
to another via the aqueous phase (for review see [8]). Kanda 
et al. observed that a nitroxide spin-labeled iacyl ganglioside 
having a critical micellar concentration (CMC) of less than 20 
/aM could be inserted from micelles into pre-formed multi- 
lamellar vesicles [9]. We have observed that MPEG1900- 
DSPE forms aqueous micellar solutions and has a CMC be- 
low 20 gM as well. Therefore, we decided to use this pegy- 
lated phospholipid as a model compound to see if it could be 
inserted and retained in rapidly cleared, pre-formed liposomes 
in sufficient quantity to achieve its biological effect, namely, 
prolonged in vivo circulation time. We also report on the rate 
of entrapped content leakage caused by the insertion process, 
and the use of this process to measure directly the 'brush' 
thickness of polymer-derivatized lipids. 
Since the seminal report on ganglioside GM1 [1], other spe- 
cific lipids have been discovered that impart prolonged in vivo 
circulation time to otherwise rapidly cleared liposomes. Poly 
(ethylene glycol)-derivatized (pegylated) phospholipid has 
been especially successful in prolonging the plasma distribu- 
tion phase [2,3], and increasing the therapeutic efficacy of 
entrapped drugs in both animal tumor models (for reviews 
see [4-6]) and in the clinic [7]. In this body of work, 
MPEG1900-DSPE is always co-dissolved with other lipids in 
an organic phase prior to hydration and self-assembly into 
liposomes. The next generation of liposome delivery systems 
will use targeting molecules to achieve site specific delivery. 
Many laboratories are now studying how to achieve this spe- 
cificity by attaching ligands such as peptides, proteins, and 
saccharides as 'pendants' on the end of polymer-derivatized 
lipids. New methods for transferring polymer-grafted lipids to 
liposomes are necessary because some pendant molecules may 
be available in minute quantities, have limited solubility and 
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Abbreviations. AUC, area under the concentration-time curve; 5,6- 
CF, 5,6-carboxyfluorescein; CH, cholesterol; CMC, critical micellar 
concentration; DPPG, 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol, 
sodium salt; DTPA-DSPE, N-diethylenetriaminepentaacetic id-l,2- 
distearoyl-sn-glycero-3-phosphoethanolamine, sod umsalt; HSPC, 
hydrogenated soy 1,2-diacyl-sn-glycero-3-phosphocholine; 
MPEG1900-DSPE, N-carbamyl-methoxypoly(ethylene glycol)-l,2-dis- 
tearoyl-sn-glycero-3-phosphoethanolamine, sodium salt, 1900 Da 
methoxy poly(ethylene glycol) fraction 
2. Materials and methods 
2.1. Materials 
Unspecified reagents were ACS grade purity or better and obtained 
from J.T. Baker Inc. (Philipsburg, NJ). The 1900 molecular weight 
fraction of methoxypoly(ethylene glycol) was attached via a carba- 
mate linkage to the amino headgroup of 1,2-distearoyl-sn-glycero-3- 
phosphoethanolamine (MPEGa900-DSPE) according to [3]. Purified 
MPEGao00-DSPE had no other lipid impurities and less than 5% 
poly(ethylene glycol) impurity as determined by thin layer chromato- 
graphy. DTPA-DSPE, an indium ion chelating lipid, was synthesized 
according to [10]. HSPC was purchased from Natterman AG (Co- 
logne, Germany), DPPG and DSPE from Avanti/Polar Lipids (Ala- 
baster, AL) and CH from Croda, Inc. (Fullerton CA). mIndium 
chloride was purchased from Amersham, Inc. (Arlington Heights, 
IL) and 5,6-carboxyfluorescein (5,6-CF) was from Molecular Probes 
(Eugene, OR). 
2.2. Liposome preparation and MPEGI9oo-DSPE insertion 
The lipid matrix of HSPC/CH/DPPG/DTPA-DSPE (52.4/45.4/2.0/ 
0.2, molar ratio) was mixed in chloroform and dried under high va- 
cuum overnight to remove residual solvent. The hydrated multilamel- 
lar vesicles were extruded repeatedly through double-stacked 0.1 lam 
pore size polycarbonate membranes (Costar/Nuclepore, Cambridge, 
MA) in a thermally jacketed, high pressure extrusion cell (Lipex, 
Vancouver, BC, Canada) as described in [11] to a final mean diameter 
range of 80 85 nm. For leakage studies, 100 mM purified 5,6-carboxy- 
fluorescein was entrapped inside the liposomes according to [12]. 
Experiments were conducted by first equilibrating the liposome dis- 
persion and a concentrated micellar MPEG1900-DSPE dispersion to 
the desired temperature. The transfer eaction was started by mixing 
aliquots to give a final theoretical 3 mol% of MPEG~900-DSPE to 
total lipid. At specified time points, the micellar material was sepa- 
rated from the liposome fraction by Sepharose 4B (Sigma Chemical 
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Co., St. Louis, MO) column chromatography. Liposome fractions in 
the void volume were pooled for analyses. 
2.3. Pharmacokinetics 
Liposomes were loaded with mindium to measure circulating plas- 
ma levels of liposomes. Preparations were incubated with the radio- 
nuclide at room temperature for 1 h, and non-chelated radiolabel 
(<10%) was removed by Sephadex G-50 (Sigma Chemical Co.) col- 
umn chromatography. Pharmacokinetic studies were performed using 
adult male Sprague-Dawley rats (205 260 g, 3 per treatment group). 
A 400-500 gl sample (~0.5 gCi mindium) was administered by tail 
vein injection. Whole blood samples of approximately 400 lal were 
collected from the retro-orbital sinus of anesthetized rats at selected 
time points. The blood samples were aliquoted into triplicate 100 #1 
samples and the DPMs in each sample were determined using a Beck- 
man/Gamma 5500 gamma counter. Pharmacokinetic evaluations were 
performed using RSTRIP software (Micromath Inc., Salt Lake City, 
UT). 
2.4. Analytical methods 
Mean liposome diameter was determined by dynamic laser light 
scattering (Coulter N4, Hialeah, FL). Net increases in mean particle 
diameter were calculated by subtracting the pre-incubation diameter 
from the liposome mean diameter measured after Sepharose 4B clean- 
up. Absorbance measurements were made with a U-2000 spectropho- 
tometer (Hitachi Instrument Co., San Jose, CA). Lipid phosphorus 
was determined according to the method of [13]. MPEG1900-DSPE, 
HSPC, and CH concentration were determined using the HPLC meth- 
od of [14] with modifications to be described elsewhere (C. Mendez, in 
preparation). 
3. Results and discussion 
Dispersing MPEG1900-DSPE at concentrations as high as 
20 mM produced a clear, pearlescent micellar solution. We 
determined the CMC of MPEG~900-DSPE by serial dilution 
of a micellar solution of assayed phosphorus concentration 
into saline, and monitoring micelle turbidity at 240 nm (Fig. 
1). Below the critical concentration, only monomers were pre- 
sent and light scattering was at a constant background level. 
Turbidity appeared and grew as the concentration of micelles 
increased. Regression analysis of the intersection point of 
scattering and background indicates the CMC for 
MPEGao00-DSPE is 5.8 gM (2.2-10.8 gM, 95% confidence 
interval range). 
The significant water solubility of MPEG~0~-DSPE sug- 
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Fig. 1. Turbidometric analysis of MPEG1900-DSPE CMC. 
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Fig. 2. Uniform shell design of time and temperature dependence of
MPEGao00-DSPE incorporation into ~80 nm diameter pre-formed 
HSPC/CH/DPPG/DTPA-DSPE (52.4/45.4/2.0/0.2, molar ratio) lipo- 
somes. Molar percentage assayed after incubation and column chro- 
matography removal of non-inserted lipid. 5 min at 20°C had 0.9 
mol% inserted. 
gested to us that, while hitherto this lipid had been co-dis- 
solved with other matrix lipids in organic solvent prior to 
hydration, it might be possible to insert it into pre-formed 
liposomes. Functional insertion would presumably increase 
plasma circulation time of the liposomes in proportion to 
the final concentration of MPEG]o00-DSPE. To test this hy- 
pothesis, we prepared pre-formed liposomes containing 2 
mol% DPPG to ensure rapid clearance in the absence of in- 
serted, functional MPEG]900-DSPE ( tv:  <1 h, [2,15]). 
The main endothermic phase transition (To) of HSPC is 
approximately 58°C (data not shown), so we prepared a 
two-factor, uniform shell design experimental matrix to exam- 
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Fig. 3. Rat plasma pharmacokinetics (mindium label) of prepara- 
tions in Fig. 2. 0.5 gCi liposomal nlindium was given by tail vein 
to treatment groups (n=3 males). Liposome preparations are as in 
Fig. 2. The dashed line is a positive control 5.5 mol% formulation 
prepared by co-dissolving MPEG1900-DSPE in organic solvent with 
other lipids. Error bars are removed for clarity, mol% inserted mea- 
sured by HPLC (©) 0.9%, (e) 1.2%, (D) 2.0%, (11) 2.4%, (zx) 2.5%, 
(A) 2.5%, (O) 2.7%, (0) 2.8%, ('7) 3.0%, (v)  3.1%. 
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Fig. 4. Distribution phase half-life as a function of mol% 
MPEGm00-DSPE of the pharmacokinetic profiles of Fig. 3. Error 
bars are standard eviation. 
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Fig. 5. Liposome diameter increase as measured by dynamic light 
scattering as a function of assayed MPEG1900-DSPE. Line is fit to 
the flexible brush model presented in [18] with 95% confidence inter- 
vals of the estimate. 
ine insertion below (50°C), at (60°C), and above (70°C) the Tc 
as a function of time. After co-incubation of liposomes and 
micelles for the specified time and temperature, the liposome 
fractions were collected by chromatography and analyzed for 
mol% MPEG1900-DSPE (Fig. 2), changes in liposome dia- 
meter, and plasma circulation time. We also co-incubated li-
posomes and micelles for 5 min at 20°C as a control, fully 
expecting virtually no insertion of MPEG1900-DSPE. To our 
surprise, this preparation was assayed at 0.9 mol% MPEG1900- 
DSPE. Insertion proceeded rapidly over the studied tempera- 
ture range (Fig. 2), also with about 1 mol% insertion after 5 
min at 60°C and nearly reached the expected theoretical max- 
imum (3 mol%) in about 1 h. Thus, virtually complete inte- 
gration of MPEG1900-DSPE into the liposome matrix can be 
achieved under these conditions. 
For liposome matrices containing pegylated phospholipids, 
extrapolation of Silvius and Zuckerman's data suggests an in 
vitro half-life of exchange rate of MPEG1900-DSPE out of the 
bilayer to be approximately 70 h [16]. Thus, if MPEG1900- 
DSPE is properly inserted under our conditions, long circula- 
tion times would be expected. This hypothesis was confirmed 
in vivo (Fig. 3). The statistical significance of the correlation 
between assayed MPEG1900-DSPE content, plasma mean re- 
sidence time, plasma distribution phase half-life, area under 
the curve, and net increase in liposome diameter was analyzed 
by the Pearson product moment coefficient [17] (Table 1). The 
correlation between chemical, physical, and pharmacokinetic 
properties of the preparations i highly significant. For in- 
stance, the relationship between distribution phase half-life 
and mol% MPEG1900-DSPE (Fig. 4) shows an increasingly 
long circulation time with increasing molar percentage. Since 
80 nm liposomes made by the extrusion method are unilamel- 
lar [11] and the MPEG1900-DSPE structure suggests negligible 
flip-flop from outer to inner bilayer leaflet, the density on the 
outer leaflet is essentially twice the assayed value. 
Invariably, there was a net increase in liposome diameter 
following incubation and clean-up which correlated very 
strongly with assayed mol% MPEG1900-DSPE and all phar- 
macokinetic parameters (Table 1). We attribute this increase 
to the formation of the flexible, polymeric 'brush'. The net 
diameter increase as a function of assayed MPEG1900-DSPE 
content was fit to the 'flexible brush' model equation [18] (Fig. 
5). Assuming that MPEGa900-DSPE density on the outer bi- 
layer is twice the assayed total, we estimate the brush thick- 
ness at 5 mol% surface density to be 6.1 nm (5.4-6.8 nm, 95% 
confidence interval). Our direct measurement, slightly larger 
than the 5 nm estimate inferred from zeta potential measure- 
ments [19], and from force-repulsive measurements on giant 
liposomes [20], may be due to different buffer conditions and 
lipid composition.. 
The significant insertion of MPEG1900-DSPE after only 5 
min at 20°C was unexpected. Since the diameter increase cor- 
related well with insertion of MPEG1900-DSPE, we explored 
the insertion phenomenon over a broader ange of tempera- 
ture and incubation time using particle size measurement as a 
rapid and convenient analytical tool (Fig. 6). For liposomes of 
this composition, the rate and extent of diameter increase (and 
inferred MPEGao00-DSPE insertion) was proportional to tern- 
Table 1 
Pearson correlation coefficient (P value in parentheses) of chemical, physical and pharmacokinetic properties of liposomes with inserted 
MPEGag00-DSPE 
Net nm increase mol% MRT T1/2 
mol% 0.838 (0.005) 
MRT 0.948 (<0.001) 0.910 (0.001) 
7"1/2 0.948 (<0.001) 0.910 (0.001) 1.000 (<0.001) 
AUC 0.976 (<0.001) 0.876 (0.002) 0.972 (<0.001) 0.974 (<0.001) 
MRT, mean residence time; Ta/2, distribution phase half-life. 
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Fig. 6. Kinetics of liposome diameter increase as a function of incu- 
bation temperature. Pre-formed liposome composition and size as in 
Fig. 1. (e) 2°C, (11) 20°C, (/,) 37°C, (0) 60°C. The 60°C sample 
was incubated for only 6 h because overnight incubation resulted in 
significant sample degradation. 
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Fig. 7. Kinetics of entrapped 100 mM 5,6-CF leakage in the contin- 
uous presence or absence of 3 mol% MPEG1900-DSPE initially in 
micelles. Pre-formed liposome composition and size as in Fig. 1. In- 
set is an enlargement of the first 5 h. Triton X-100 is added at the 
arrow to completely lyse the vesicles for complete leakage. (©) 
37°C+(no MPEG1900-DSPE), (e) 37°C+(MPEG1900-DSPE), (n) 
60°C+(no MPEG1900-DSPE), (m) 60°C + (MPEG1900-DSPE). 
perature. Only at 2°C was there no significant increase in 
diameter over 24 h. 
The asymmetric addition of lipid might be expected to 
cause membrane defects resulting in leakage. We studied leak- 
age at 37°C and 60°C with and without inserted MPEG1900- 
DSPE by encapsulating highly concentrated and fluorescence- 
quenched 5,6-CF (Fig. 7). Saline or MPEG1900-DSPE micelles 
in saline were added at time zero, and aliquots were removed 
at specified time points for determining the increase of fluo- 
rescence due to leaked 5,6-CF. Triton X-100 (Sigma Chemical 
Co.) was added to samples at 6 h post addition to determine 
100% leakage. Although Fig. 6 indicates a considerable size 
increase at 37°C due to insertion of MPEG1900-DSPE, there 
was essentially no dye leakage even after 24 h continuous 
incubation. There was less than 8% dye leakage after 5 h at 
600C in the presence of MPEG1900-DSPE, only a one-third 
increase over leakage in its absence (Fig. 7, inset). Thus, the 
insertion process results in little if any leakage during and 
after the procedure, suggesting that contents are likely to re- 
main entrapped uring preparation and storage periods. 
MPEG1900-DSPE insertion is a mild and efficient procedure. 
The insertion rate is temperature dependent, but orders of 
magnitude faster than the exchange rate out of the bilayer 
[16] resulting in the transfer of long in vivo circulation proper- 
ties to pre-formed liposomes. Since functional transfer of pe- 
gylated lipids is feasible, it may be a useful method by which 
custom libraries of targeted delivery systems can be created 
from a base formulation of liposome-entrapped drug and a 
collection of ligand-polymer-lipid conjugates. Future work 
will explore the intricate relationships between acceptor lipo- 
some composition, polymer chain length, lipid anchor, and 
physicochemical properties of the targeting ligand. 
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